Forsa Egg Bank
Description
Forsa Egg Bank is a frozen donor egg bank providing premium mature donor oocytes for IVF clinics. The bank presents itself as a quality-focused provider with a primary donor base consisting of Caucasian phenotype donors, while also noting that other phenotypes may be available upon request.
The mission of Forsa Egg Bank is to support fertility clinics with safe, high-quality donor oocytes through strict donor selection, validated genetic screening, certified laboratory protocols and careful transportation. Its operating approach is clinic-oriented, with emphasis on regulatory alignment, documentation adaptation and integration into the clinical and regulatory environment of partner clinics.
Through its international operations, Forsa Egg Bank works with regulated markets and partner clinics requiring reliable donor supply, validated genetics and a scalable donor program.
Donor types and services
Forsa Egg Bank provides frozen mature donor oocytes. Donor documentation includes phenotypic traits, medical history, genetic profile, family tree and a genetic counsellor’s conclusion. The bank states that oocytes are selected before vitrification, with only mature and morphologically high-quality oocytes frozen.
The bank’s public website includes individual donor catalogue pages with donor code, date of birth, race, blood type, height, weight, eye colour, hair colour, hair type, number of oocytes and sections for genetic tests, medical history and donor profile. Full access and order processing appear to be handled through inquiry/request forms rather than an unrestricted public donor portal.
Forsa Egg Bank provides customer service through direct contact by phone, email and its website contact form. The public website is primarily in English and is oriented toward IVF clinics and professional partners.
Genetic test panel
Forsa Egg Bank states that each donor program includes extended medical checks and screening for 420+ genetic conditions using CarrierSeq. The website specifically mentions Karyotype, CF, SMA, Fragile X and additional conditions. Testing is stated to be conducted in certified EU laboratories.
The bank also highlights ESHRE-based morphological grading, strict selection before vitrification and certified Cryotech protocols supervised by its IVF Lab Director. Forsa reports a survival rate above 90%, and the website lists partner-experience results including 93+% survival rate, 85+% fertilization rate, 52% blastulation rate and 63% clinical pregnancy rate.
Origin and locations
Registered and operating under European regulations in Slovakia having roots from Ukraine. The public website lists international clinic-facing operations and contact details by phone and email.
Privately owned, founder and CEO Ms. Anna Forsa.